(the black thick segment indicates the aortic arch and the origin of the brachiocefalic trunk)
Figure 1: FDG Upatake in PET-CT before (upper) and after (lower) the introduction of MTX

T (C)

CRP
(mg/L)

CST
(mg/day)

MTX
(mg/week)

TCZ

T0
38
25
115
15

i.v.
8mg/kg/4weeks

3 months
36,3
1,5
6,5
15

i.v.
8mg/kg/4weeks

4 months
36,3
2,5
2,5
15

s.c.
162 mg/week

10 months
36,5
0,5
1,25
15

s.c.
162 mg/week

T: body temperature, C: Celsius; CRP: CreactiveProtein (nv<0.5 mg/L), CST: corticosteroids, prednisone equivalent; MTX: methotrexate; TCZ: tocilizumab; i.v.: intravenous; s.c.:subcutaneously
Table 1: Effect of  TCZ on temperature and C-reactive Protein